logo

DWTX

DogwoodยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

DWTX Profile

Dogwood Therapeutics, Inc.

A development-stage biotechnology company developing novel antiviral therapeutics

Biological Technology
02/28/2012
12/17/2020
NASDAQ Stock Exchange
4
12-31
Common stock
44 Milton Avenue, Alpharetta, GA 30009
--
Dogwood Therapeutics, Inc., originally incorporated in Alabama on February 28, 2012, was later changed to a Nevada company. The company is a development-stage biotechnology company focused on advancing novel antiviral therapies to treat diseases associated with abnormal immune responses triggered by viruses, such as fibromyalgia (" FM ").